Latest News and Press Releases
Want to stay updated on the latest news?
-
Elevai Labs Inc. Subsidiary, Elevai Skincare, Launches S-Series Root Renewal System, Marking Entry into Hair Care Market
-
Elevai Labs Inc. Announces Record-Breaking Sales Month in 2024 for Elevai Skincare Division
-
Elevai Labs Inc. Announces Reverse Stock Split to Maintain Nasdaq Listing Compliance
-
Elevai Labs Inc. Announces Withdrawal of Offer to Exchange and Plans to Reassess
-
/CORRECTION/ Elevai Labs Inc. Reports Financial Results for the Third Fiscal Quarter of 2024 and Provides Business Update
-
Elevai Labs Inc. Reports Financial Results for the Second Fiscal Quarter of 2024 and Provides Business Update
-
Elevai Labs Inc. Announces Update and Extension of Pending Offer to Exchange
-
Elevai Biosciences Engages Leading CRO to Support Regulatory Planning Efforts and Pre-IND Meeting with the FDA for EL-22 For The Treatment of Obesity
-
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Highlights Past Positive Preclinical Data Showing Potential of EL-32, A Dual Myostatin & Activin-A Bl
-
Elevai Labs Inc. Commences Offer to Exchange Up to 15,000,000 shares of Common Stock For Shares of Non Tradable. Locked Up Series B Preferred Stock